参考文献/References:
[1]Jacques F,Isabelle S,Rajesh D,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].International Journal of Cancer,2015,136(5):E359-E386. [2]Yun SS,Han KY.Screening and Early Detection of Gastric Cancer:East Versus West[J].Surgical Clinics of North America,2015,95(5):1053-1066. [3]Siegel RL,Fedewa SA,Miller KD,et al.Cancer statistics for Hispanics/Latinos,2015[J].CA:A Cancer Journal for Clinicians,2015. [4]Beeharry MK,Liu WT,Yan M,et al.New blood markers detection technology: A leap in the diagnosis of gastric cancer[J].World Journal of Gastroenterology,2016,22(3):12. [5]Eaves CJ.Cancer stem cells:Here,there,everywhere[J].Nature,2008,456(7222):581-582. [6]Woodward WA,Sulman EP.Cancer stem cells: markers or biomarkers[J]Cancer&Metastasis Reviews,2008,27(3):459-470. [7]Al-Hajj M,Wicha MS,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proceedings of the National Academy of Sciences,2003,100(7):3983-3988. [8]Thapa R,Wilson GD.The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer[J].Stem Cells International,2016(2016):2087204. [9]Shigeo T,Tomoyuki O,Shuiping T,et al.Identification of gastric cancer stem cells using the cell surface marker CD44[J].Stem Cells,2010,27(5):1006-1020. [10]Weiswald LB,Bellet D,Dangles-Marie V.Spherical Cancer Models in Tumor Biology[J].Neoplasia,2015,17(1):1-15. [11]Zhang C,Li C,He F,et al.Identification of CD44+CD24+ gastric cancer stem cells[J].J Cancer Res Clin Oncol,2011,137(11):1679-1686. [12]Yoon C,Park DJ,Schmidt B,et al.CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance[J].Clinical Cancer Research,2014,20(15):3974-3988. [13]Yu D,Shin HS,Choi G,et al.Proteomic analysis of CD44(+)and CD44 gastric cancer cells[J].Molecular&Cellular Biochemistry,2014,396(1-2):213-220. [14]O’Connor,Michael L,Xiang D,et al.Cancer stem cells:A contentious hypothesis now moving forward[J].Cancer Letters,2014,344(2):180-187. [15]Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3(7):730-737. [16]Daisuke I,Takatsugu I,Keisuke M,et al.Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc[J].Stem Cells,2017,35(9):2027-2036. [17]Alamgeer M,Peacock CD,Matsui W,et al.Cancer stem cells in lung cancer:Evidence and controversies[J].Respirology,2013,18(5):757-764. [18]Jing H,Toshio F,Syed RH,et al.Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma[J].BMC Cancer,2014(14):173. [19]Li C,Heidt DG,Dalerba P,et al.Identification of pancreatic cancer stem cells[J].Cancer Res,2007,67(3):1030-1037. [20]Taro Y,Xin WW.Cancer stem cells in the development of liver cancer[J].Journal of Clinical Investigation,2013,123(5):1911-1918. [21]Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63(18):5821-5828. [22]Li T,Su Y,Mei Y,et al.ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome.[J].Laboratory investigation; A Journal of Technical Methods and Pathology,2010,90(2):234-244. [23]Ishimoto T,Oshima H,Oshima M,et al.CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis[J].Cancer Science,2010,101(3):673-678. [24]Lau WM,Teng E,Chong HS,et al.CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells[J].Cancer Research,2014,74(9):2630-2641. [25]Fukamachi H,Shimada S,Ito K,et al.CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation[J].Cancer ence,2011,102(7):1313-1321. [26]Nishikawa S,Konno M,Hamabe A,et al.Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy[J].International Journal of Oncology,2013,42(4):1437-1442. [27]Negi LM,Talegaonkar S,Jaggi M,et al.Role of CD44 in tumour progression and strategies for targeting[J].Journal of Drug Targeting,2012,20(7):561. [28]Bourguignon LY,Shiina M,Li JJ.Hyaluronan-CD44 interaction promotes oncogenic signaling,microRNA functions,chemoresistance,and radiation resistance in cancer stem cells leading to tumor progression[J].Advances in Cancer Research,2014,123(22):255-275. [29]Ling L,Xinbao H,Jun Q,et al.Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice[J].Gastroenterology,2014,6(10):165. [30]Dotse E,Bian Y.Isolation of colorectal cancer stem-like cells[J].Cytotechnology,2016,68(4):609-619. [31]Leung EL,Fiscus RR,Tung JW,et al.Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties[J].PLoS One,2010,5(11):e14062. [32]Michishita M,Ezaki S,Ogihara K,et al.Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line[J].Research in Veterinary ence,2014,96(2):315-322. [33]Meng E,Long B,Sullivan P,et al.CD44+/CD24 ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival[J].Clinical & Experimental Metastasis,2012,29(8):939-948. [34]Luciana A,Douglas G,Cristiane S,et al.Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells[J].Cancers,2016,8(1):7. [35]Bhardwaj A,Arora S,Prajapati VK,et al.Cancer"stemness"-regulating microRNAs:role,mechanisms and therapeutic potential[J].Current Drug Targets,2013,14(10):1175. [36]Borah A,Raveendran S,Rochani A,et al.Targeting self-renewal pathways in cancer stem cells:clinical implications for cancer therapy[J].Oncogenesis,2015,4(11):e177. [37] Es-Haghi M,Soltanian S,Dehghani H.Perspective:Cooperation of Nanog,NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells[J].Tumor Biology,2015,37(2):1559-1565. [38]Matsuoka J,Yashiro M,Sakurai K,et al.Role of the Stemness Factors Sox2,Oct3/4,and Nanog in Gastric Carcinoma[J].Journal of Surgical Research,2012,174(1):130-135. [39]Siddique HR,Saleem M.Role of BMI1,a stem cell factor,in cancer recurrence and chemoresistance:preclinical and clinical evidences[J].Stem Cells,2012,30(3):372-378. [40]Rocco A,Compare D,Nardone G.Cancer stem cell hypothesis and gastric carcinogenesis:Experimental evidence and unsolved questions[J].World Journal of Gastrointestinal Oncology,2012,4(3):54-59. [41]Brungs D,Aghmesheh M,Vine KL,et al.Gastric cancer stem cells:evidence,potential markers,and clinical implications[J].Journal of Gastroenterology,2016,51(4):313-326. [42]Wu C,Xie Y,Gao F,et al.Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers[J].Gene,2013,525(1):18-25.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(20):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,31(20):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,31(20):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,31(20):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(20):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,31(20):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,31(20):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,31(20):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[9]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(20):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[10]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Medical Information,2019,32(20):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]